Current Bids
Supply Chain Management
Sourcing & Contract Management
Request for Proposal
Bid Number #: 180025
RFx Name: CSP - G5 LIM Panel Replacement
RFx Information:
Open: Jun 6, 2019 11:00 PM
Close: Jul 16, 2019 1:30 PM
Contact Information:
Name: Peaches Engish
Email: ecwashin@mdanderson.org
Phone: 713-792-3389
The University of Texas MD Anderson Cancer Center
CSP - G5 LIM Panel Replacement - 180025
Introduction to MD Anderson
MD Anderson is known throughout the world for high-quality cancer care, research, academic programs and prevention services. Since its establishment in 1941, MD Anderson has made major contributions to improve the outlook for cancer patients everywhere.
MD Anderson was one of the first three federally designated comprehensive cancer centers by the National Cancer Act of 1971. A survey of health professionals has routinely ranked MD Anderson as one of the two premier cancer centers in the nation for the past eight years. Over 55,000 persons annually seek care at MD Anderson. The team approach to cancer care, pioneered at MD Anderson, has been strengthened by consolidating specialty clinics into multi-disciplinary care centers that allow patients to receive more ambulatory care and treatment in a single location.
MD Anderson offers one of the largest bone marrow and stem cell transplantation programs, as well as clinical trials to improve existing therapies. Teams of clinical specialists collaborate with scientists on problems of common interest and test theories that shorten the application of better treatment methods. Translational research studies are responsible for the promising field of chemoprevention, which uses synthetic vitamins to reverse pre-malignant lesions and halt the recurrence of some cancers, and for innovative gene therapy strategies being evaluated for several forms ofcancer.
With faculty and staff working in more than 30 buildings in the greater Houston area and in central Texas, MD Anderson is the largest freestanding cancer center in the world. The physical plant covers more than 11 million square feet, featuring the latest equipment and facilities to support growing needs in outpatient and inpatient care, research, prevention and education. It includes inpatient hospital facilities with 571 beds.
Construction projects include the addition of 12 floors that can accommodate more than 300 new inpatient beds in Alkek Hospital on the North Campus; two new research buildings on the South Campus that will house the Center for Advanced Biomedical Imaging Research and Center for Targeted Therapy as part of the McCombs Institute; and MD Anderson's first facility on its Mid Campus, a 25-story building to support current office space and future growth needs.
In addition to its main campus in the Texas Medical Center and two research campuses in Bastrop County, Texas, MD Anderson has developed a number of local, national and international affiliations
RFx Overview
The Owner will receive Proposals at the time and location described below. July 16, 2019 at 1:30 pm CST Physical Address for Courier Delivery: The University of Texas MD Anderson Cancer Center Facilities Planning Design Construction 6900 Fannin , Suite FHB9.1085 Houston, Texas 77030 Attn: Eulalia English Project Scope: Requesting construction services to replace an approximate total of 50 Line Isolation Monitor electrical panels in the Alkek G5 OR Suites. Each LIM location will need require a new panel interior and a new enclosure and cover. Each OR will require that a new LIM alarm annunciator be added or replaced. Provide Building Monitoring System (BMS) cabling, conduit and terminations for the LIM panels as specified in the Construction Documents. Above the ceiling, at or near each LIM panel location a smoke transfer boot (duct) will be removed, and the fire rated wall penetration sealed as designed in the Construction Documents.
Questions related to this RFP must be sent via the information request form. All questions must be received no later than June 19, 2019 4:00 PM. Questions received after this time will not be accepted. Questions will not be answered via telephone. All answers to any questions or inquiries will be posted on the webpage for all Suppliers to access. It is the intent of MD Anderson to respond to all questions and concerns; however, MD Anderson shall reserve the right to decline to respond to any question or concern.
It is important to note that the supplier or suppliers selected to develop MD Anderson's RFP are not automatically qualified to engage with the Institution for purposes of implementing the recommended strategy or solutions. The engagement of contracted services for implementation can, at MD Anderson's discretion, be solicited via a second and separate Request for Proposal.
Standard Riders and Agreements
180025 Addendum 1 - Sign In Sheet and HUB Tip Sheet.pdf
180025 Addendum 2 - RFI and Answers.pdf
180025 Addendum 3 - Revised Bid Closing Date & Location.pdf
Attachment A - Draft Agreement.pdf
Attachment B HUB Policy Rider 104C.pdf
Attachment D - Pricing_and_Delivery_Proposal_OGC Approved.pdf
***Interested suppliers should also note that Subcontracting Opportunities are
probable in connection with this solicitation. Please review the HUB Subcontracting Tip Sheet
***RFx refers to RFP, RFQ, RFI, ITB, etc.